IGF2 and liver cancer: Notably, experimental rescue of miR-493-5p promoted an anti-cancer response by negatively regulating the expression of insulin-like growth factor 2 (IGF2)-derived oncomir miR-483-3p in liver cancer cell lines exhibiting IGF2 LOI.